Literature DB >> 6249634

The response of cyclic 3',5'-AMP and cyclic 3',5'-GMP phosphodiesterases to experimental diabetes.

B Perez de Gracia, A R Rhoads, W L West.   

Abstract

Alloxan diabetes caused a decrease in cyclic AMP phosphodiesterase in all affected rat tissues. Cyclic GMP phosphodiesterase activity was, however, decreased in adipose and liver, but increased increased in heart and uterus.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6249634     DOI： 10.1007/bf01978592

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  13 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Stimulation of a low Km phosphodiesterase from liver by insulin and glucagon.

Authors:  E G Loten; F D Assimacopoulos-Jeannet; J H Exton; C R Park
Journal:  J Biol Chem       Date:  1978-02-10       Impact factor: 5.157

3.  Effect of insulin and lipolytic agents on rat adipocyte low Km cyclic adenosine 3':5'-monophosphate phosphodiesterase.

Authors:  B Zinman; C H Hollenberg
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

4.  An effect of insulin on cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in fat cells.

Authors:  V Manganiello; M Vaughan
Journal:  J Biol Chem       Date:  1973-10-25       Impact factor: 5.157

5.  An effect of insulin on the adenosine 3':5'-cyclic monophosphate phosphodiesterase and guanosine 3':5'-cyclic monophosphate phosphodiesterase activities in the perfused Langendorff and working hearts of normal and diabetic rats.

Authors:  I Das; E B Chain
Journal:  Biochem J       Date:  1972-07       Impact factor: 3.857

6.  Cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate phosphodiesterase activities are under separate genetic control.

Authors:  T R Russell; I H Pastan
Journal:  J Biol Chem       Date:  1974-12-25       Impact factor: 5.157

7.  Stimulation of adenosine 3',5'-monophosphate hydrolysis by guanosine 3',5'-monophosphate.

Authors:  J A Beavo; J G Hardman; E W Sutherland
Journal:  J Biol Chem       Date:  1971-06-25       Impact factor: 5.157

8.  Influence of insulin on cyclic 3',5'-AMP phosphodiesterase activity in liver, skeletal muscle, adipose tissue, and kidney.

Authors:  G Senft; G Schultz; K Munske; M Hoffmann
Journal:  Diabetologia       Date:  1968-12       Impact factor: 10.122

9.  An effect of insulin on adipose-tissue adenosine 3':5'-cyclic monophosphate phosphodiesterase.

Authors:  E G Loten; J G Sneyd
Journal:  Biochem J       Date:  1970-11       Impact factor: 3.857

10.  Cyclic nucleotide phosphodiesterases, insulin and thyroid hormones.

Authors:  C Correze; R Auclair; J Nunez
Journal:  Mol Cell Endocrinol       Date:  1976 Jun-Jul       Impact factor: 4.102
View more
  1 in total

1.  Identification of the molecular basis for phosphorylase hypersensitivity in cultured diabetic cardiomyocytes.

Authors:  J A Buczek-Thomas; T B Miller
Journal:  Mol Cell Biochem       Date:  1995-04-26       Impact factor: 3.396
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.